top of page
Company Profile
Nanoglia, Inc., is a global new company that specialized in research
and development of innovative medicines using Nanotechnology
for brain diseases, Osteoathritis, and neuropathic pain.
History
2022.08 과학기술일자리진흥원 충남대학교 "대학기술경영촉진(TMC)사업" 선정
2022.08 대전테크노파크 "기술거래촉진네트워크사업" 선정
2020.11 Subsidiary of Chungnam National University Technology Holding Company
2020.05 Fund raising from 5 shareholders and 3 directors selected
2019.04 Established Nanoglia, Inc.
Patent
2022.08 Transfer
No. 10-2113090 : p38 또는 이를 코딩하는 유전자의 발현을 억제하는 제제가 함유된 나노입자를 포함하는 신경병증성통증 예방 또는 치료용 조성
Composition for preventing or treating neuropathic pain comprising nanoparticle containing an agent for inhibiting expression of p38 or a gene encoding the same
bottom of page